newsfilter
← Latest News
GlobeNewswire·

Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

  • Tango Therapeutics management team will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026 at 8:35 AM EDT.
  • The live webcast will be accessible via the "Events & Presentations" tab on the Investors page of the company website on the event date.
  • A replay of the webcast will be archived on the company website for 90 days following the presentation.
  • Tango Therapeutics is a clinical-stage biotechnology company utilizing synthetic lethality to discover & develop cancer therapies.
  • Investor inquiries can be directed to Elizabeth Hickin at ehickin@tangotx.com.
  • Media inquiries should be directed to Amanda Lazaro at 1AB (amanda@1abmedia.com).